AI
GMAB icon

Atria Investments’s Genmab GMAB Stock Holding History

Atria Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$836K Sell
30,440
-14,976
-33% -$398K 0.01% 1211
2026
Q1 		$1.22M Buy
45,416
+2,954
+7% +$88.5K 0.01% 953
2025
Q4 		$1.31M Buy
42,462
+12,900
+44% +$402K 0.01% 928
2025
Q3 		$907K Sell
29,562
-1,003
-3% -$24.4K 0.01% 1102
2025
Q2 		$631K Sell
30,565
-475
-2% -$9.75K 0.01% 1301
2025
Q1 		$608K Buy
31,040
+1,739
+6% +$36.5K 0.01% 1239
2024
Q4 		$612K Sell
29,301
-19,174
-40% -$421K 0.01% 1224
2024
Q3 		$1.18M Buy
48,475
+14,424
+42% +$386K 0.01% 890
2024
Q2 		$856K Buy
34,051
+245
+0.7% +$6.95K 0.01% 1021
2024
Q1 		$1.01M Sell
33,806
-13,398
-28% -$394K 0.01% 955
2023
Q4 		$1.5M Sell
47,204
-7,708
-14% -$242K 0.02% 715
2023
Q3 		$1.94M Buy
54,912
+19,254
+54% +$734K 0.03% 579
2023
Q2 		$1.36M Sell
35,658
-3,512
-9% -$140K 0.02% 712
2023
Q1 		$1.48M Sell
39,170
-6,819
-15% -$262K 0.03% 652
2022
Q4 		$1.95M Sell
45,989
-4,239
-8% -$175K 0.04% 522
2022
Q3 		$1.61M Buy
+50,228
New +$1.76M 0.04% 558
2022
Q2 		– Sell
-30,346
Closed -$1.1M – 799
2022
Q1 		$1.1M Sell
30,346
-5,765
-16% -$198K 0.02% 813
2021
Q4 		$1.43M Sell
36,111
-1,754
-5% -$73.1K 0.03% 688
2021
Q3 		$1.66M Buy
37,865
+12,188
+47% +$547K 0.03% 605
2021
Q2 		$1.05M Buy
+25,677
New +$991K 0.02% 738
2021
Q1 		– Sell
-31,713
Closed -$1.29M – 726
2020
Q4 		$1.29M Buy
31,713
+1,009
+3% +$37.7K 0.03% 583
2020
Q3 		$1.12M Sell
30,704
-3,851
-11% -$139K 0.03% 525
2020
Q2 		$1.17M Buy
+34,555
New +$942K 0.04% 464
2020
Q1 		– Sell
-25,065
Closed -$560K – 792
2019
Q4 		$560K Buy
+25,065
New +$547K 0.02% 742

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Atria Investments's GMAB Position: Q2 2026 in Review

Atria Investments reduced its Genmab (GMAB) stake by 33% in Q2 2026, selling an estimated $398K and leaving 30,440 shares worth $836K. The position accounts for 0.01% of the portfolio, ranked #1211.

Atria Investments first reported a position in GMAB in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.95M in Q4 2022. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Atria Investments held 30,440 shares of Genmab worth $836K as of Q2 2026.
  • Atria Investments sold 14,976 Genmab shares in Q2 2026, an estimated $398K.
  • Genmab made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1211 holding.
  • Atria Investments first reported a position in Genmab in Q4 2019 and has held it in 24 quarters since.
  • Atria Investments's Genmab position peaked at $1.95M in Q4 2022.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.